Drug Profile
Ciprofloxacin - Original BioMedicals
Alternative Names: A 03; CCM-ciprofloxacinLatest Information Update: 11 Sep 2023
Price :
$50
*
At a glance
- Originator Original BioMedicals
- Class Anti-infectives; Antibacterials; Carboxylic acids; Cyclopropanes; Fluoroquinolones; Piperazines; Small molecules
- Mechanism of Action DNA gyrase inhibitors; DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Gram-negative infections; Gram-positive infections
Most Recent Events
- 11 Sep 2023 Discontinued - Preclinical for Gram-negative infections in Taiwan (unspecified route)
- 11 Sep 2023 Discontinued - Preclinical for Gram-positive infections in Taiwan (unspecified route)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Gram-negative-infections in Taiwan